nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—FGFR3—germ cell cancer	0.367	0.69	CbGaD
Pazopanib—KIT—germ cell cancer	0.164	0.31	CbGaD
Pazopanib—UGT1A1—Etoposide—germ cell cancer	0.0268	0.146	CbGbCtD
Pazopanib—ABCG2—Dactinomycin—germ cell cancer	0.0262	0.142	CbGbCtD
Pazopanib—CYP2C8—Ifosfamide—germ cell cancer	0.0165	0.0895	CbGbCtD
Pazopanib—ABCG2—Cisplatin—germ cell cancer	0.015	0.0817	CbGbCtD
Pazopanib—ABCG2—Etoposide—germ cell cancer	0.0148	0.0803	CbGbCtD
Pazopanib—SLCO1B1—Methotrexate—germ cell cancer	0.0123	0.0668	CbGbCtD
Pazopanib—ABCG2—Methotrexate—germ cell cancer	0.00975	0.0531	CbGbCtD
Pazopanib—ABCB1—Dactinomycin—germ cell cancer	0.00943	0.0513	CbGbCtD
Pazopanib—CYP2C8—Etoposide—germ cell cancer	0.00786	0.0428	CbGbCtD
Pazopanib—CYP3A4—Ifosfamide—germ cell cancer	0.00667	0.0363	CbGbCtD
Pazopanib—CYP1A2—Etoposide—germ cell cancer	0.00609	0.0331	CbGbCtD
Pazopanib—ABCB1—Vinblastine—germ cell cancer	0.00591	0.0321	CbGbCtD
Pazopanib—CYP2D6—Vinblastine—germ cell cancer	0.00557	0.0303	CbGbCtD
Pazopanib—ABCB1—Cisplatin—germ cell cancer	0.00542	0.0295	CbGbCtD
Pazopanib—ABCB1—Etoposide—germ cell cancer	0.00532	0.029	CbGbCtD
Pazopanib—CYP3A4—Vinblastine—germ cell cancer	0.00354	0.0193	CbGbCtD
Pazopanib—ABCB1—Methotrexate—germ cell cancer	0.00352	0.0191	CbGbCtD
Pazopanib—CYP3A4—Etoposide—germ cell cancer	0.00319	0.0174	CbGbCtD
Pazopanib—PLK4—Teniposide—Etoposide—germ cell cancer	0.00136	1	CbGdCrCtD
Pazopanib—Anaemia—Bleomycin—germ cell cancer	0.000162	0.00205	CcSEcCtD
Pazopanib—Myocardial infarction—Cisplatin—germ cell cancer	0.000162	0.00205	CcSEcCtD
Pazopanib—Anorexia—Vinblastine—germ cell cancer	0.000161	0.00205	CcSEcCtD
Pazopanib—Stomatitis—Cisplatin—germ cell cancer	0.000161	0.00204	CcSEcCtD
Pazopanib—Eye disorder—Ifosfamide—germ cell cancer	0.000161	0.00204	CcSEcCtD
Pazopanib—Flushing—Ifosfamide—germ cell cancer	0.000159	0.00202	CcSEcCtD
Pazopanib—Cardiac disorder—Ifosfamide—germ cell cancer	0.000159	0.00202	CcSEcCtD
Pazopanib—Neutropenia—Etoposide—germ cell cancer	0.000159	0.00201	CcSEcCtD
Pazopanib—Melaena—Methotrexate—germ cell cancer	0.000158	0.00201	CcSEcCtD
Pazopanib—Leukopenia—Bleomycin—germ cell cancer	0.000157	0.00199	CcSEcCtD
Pazopanib—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000156	0.00198	CcSEcCtD
Pazopanib—Angiopathy—Ifosfamide—germ cell cancer	0.000156	0.00198	CcSEcCtD
Pazopanib—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000155	0.00196	CcSEcCtD
Pazopanib—Skin exfoliation—Methotrexate—germ cell cancer	0.000155	0.00196	CcSEcCtD
Pazopanib—Chills—Ifosfamide—germ cell cancer	0.000154	0.00196	CcSEcCtD
Pazopanib—Cough—Bleomycin—germ cell cancer	0.000153	0.00194	CcSEcCtD
Pazopanib—Paraesthesia—Vinblastine—germ cell cancer	0.000152	0.00193	CcSEcCtD
Pazopanib—Alopecia—Ifosfamide—germ cell cancer	0.000152	0.00193	CcSEcCtD
Pazopanib—Infestation NOS—Etoposide—germ cell cancer	0.000151	0.00192	CcSEcCtD
Pazopanib—Infestation—Etoposide—germ cell cancer	0.000151	0.00192	CcSEcCtD
Pazopanib—Anaemia—Dactinomycin—germ cell cancer	0.000151	0.00191	CcSEcCtD
Pazopanib—Bradycardia—Cisplatin—germ cell cancer	0.000151	0.00191	CcSEcCtD
Pazopanib—Mental disorder—Ifosfamide—germ cell cancer	0.000151	0.00191	CcSEcCtD
Pazopanib—Malnutrition—Ifosfamide—germ cell cancer	0.00015	0.0019	CcSEcCtD
Pazopanib—Erythema—Ifosfamide—germ cell cancer	0.00015	0.0019	CcSEcCtD
Pazopanib—Acute coronary syndrome—Etoposide—germ cell cancer	0.000149	0.00189	CcSEcCtD
Pazopanib—Myalgia—Bleomycin—germ cell cancer	0.000149	0.00189	CcSEcCtD
Pazopanib—Chest pain—Bleomycin—germ cell cancer	0.000149	0.00189	CcSEcCtD
Pazopanib—Myocardial infarction—Etoposide—germ cell cancer	0.000148	0.00188	CcSEcCtD
Pazopanib—Stomatitis—Etoposide—germ cell cancer	0.000147	0.00187	CcSEcCtD
Pazopanib—Jaundice—Etoposide—germ cell cancer	0.000147	0.00187	CcSEcCtD
Pazopanib—Decreased appetite—Vinblastine—germ cell cancer	0.000147	0.00187	CcSEcCtD
Pazopanib—Mouth ulceration—Methotrexate—germ cell cancer	0.000146	0.00186	CcSEcCtD
Pazopanib—Urinary tract disorder—Cisplatin—germ cell cancer	0.000146	0.00186	CcSEcCtD
Pazopanib—Leukopenia—Dactinomycin—germ cell cancer	0.000146	0.00185	CcSEcCtD
Pazopanib—Connective tissue disorder—Cisplatin—germ cell cancer	0.000146	0.00185	CcSEcCtD
Pazopanib—PIP4K2C—endocrine gland—germ cell cancer	0.000146	0.00147	CbGeAlD
Pazopanib—Urethral disorder—Cisplatin—germ cell cancer	0.000145	0.00184	CcSEcCtD
Pazopanib—EPHB6—pituitary gland—germ cell cancer	0.000145	0.00147	CbGeAlD
Pazopanib—PDGFRB—eye—germ cell cancer	0.000145	0.00147	CbGeAlD
Pazopanib—Pain—Vinblastine—germ cell cancer	0.000145	0.00184	CcSEcCtD
Pazopanib—KDR—decidua—germ cell cancer	0.000145	0.00146	CbGeAlD
Pazopanib—MAP2K5—decidua—germ cell cancer	0.000145	0.00146	CbGeAlD
Pazopanib—FLT4—head—germ cell cancer	0.000144	0.00146	CbGeAlD
Pazopanib—FGF1—spinal cord—germ cell cancer	0.000144	0.00146	CbGeAlD
Pazopanib—PLK4—brain—germ cell cancer	0.000144	0.00146	CbGeAlD
Pazopanib—LCK—bone marrow—germ cell cancer	0.000144	0.00146	CbGeAlD
Pazopanib—PIP4K2C—head—germ cell cancer	0.000144	0.00145	CbGeAlD
Pazopanib—LIMK2—cerebellum—germ cell cancer	0.000143	0.00145	CbGeAlD
Pazopanib—Hepatobiliary disease—Etoposide—germ cell cancer	0.000143	0.00181	CcSEcCtD
Pazopanib—Oedema—Bleomycin—germ cell cancer	0.000143	0.00181	CcSEcCtD
Pazopanib—STK10—gonad—germ cell cancer	0.000142	0.00144	CbGeAlD
Pazopanib—CSF1R—skin of body—germ cell cancer	0.000142	0.00144	CbGeAlD
Pazopanib—Infection—Bleomycin—germ cell cancer	0.000142	0.0018	CcSEcCtD
Pazopanib—FLT1—medulla oblongata—germ cell cancer	0.000142	0.00143	CbGeAlD
Pazopanib—STK10—uterus—germ cell cancer	0.000142	0.00143	CbGeAlD
Pazopanib—FGFR2—adrenal gland—germ cell cancer	0.000142	0.00143	CbGeAlD
Pazopanib—PDGFRA—gonad—germ cell cancer	0.000141	0.00143	CbGeAlD
Pazopanib—CSF1R—decidua—germ cell cancer	0.000141	0.00143	CbGeAlD
Pazopanib—TAOK3—uterus—germ cell cancer	0.000141	0.00143	CbGeAlD
Pazopanib—Vision blurred—Ifosfamide—germ cell cancer	0.000141	0.00179	CcSEcCtD
Pazopanib—PDGFRA—uterus—germ cell cancer	0.00014	0.00142	CbGeAlD
Pazopanib—EPHB6—medulla oblongata—germ cell cancer	0.00014	0.00142	CbGeAlD
Pazopanib—Thrombocytopenia—Bleomycin—germ cell cancer	0.00014	0.00177	CcSEcCtD
Pazopanib—FGF1—female gonad—germ cell cancer	0.00014	0.00141	CbGeAlD
Pazopanib—FLT4—testis—germ cell cancer	0.00014	0.00141	CbGeAlD
Pazopanib—PLK4—lymph node—germ cell cancer	0.000139	0.00141	CbGeAlD
Pazopanib—Myalgia—Dactinomycin—germ cell cancer	0.000139	0.00176	CcSEcCtD
Pazopanib—LCK—female gonad—germ cell cancer	0.000139	0.00141	CbGeAlD
Pazopanib—PIP4K2C—testis—germ cell cancer	0.000139	0.0014	CbGeAlD
Pazopanib—TAOK3—pituitary gland—germ cell cancer	0.000138	0.0014	CbGeAlD
Pazopanib—Eye disorder—Cisplatin—germ cell cancer	0.000138	0.00176	CcSEcCtD
Pazopanib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000138	0.00175	CcSEcCtD
Pazopanib—Anaemia—Ifosfamide—germ cell cancer	0.000138	0.00175	CcSEcCtD
Pazopanib—MAP3K2—endocrine gland—germ cell cancer	0.000138	0.0014	CbGeAlD
Pazopanib—FGFR1—testis—germ cell cancer	0.000138	0.00139	CbGeAlD
Pazopanib—Flushing—Cisplatin—germ cell cancer	0.000137	0.00174	CcSEcCtD
Pazopanib—Cardiac disorder—Cisplatin—germ cell cancer	0.000137	0.00174	CcSEcCtD
Pazopanib—FGFR2—spinal cord—germ cell cancer	0.000136	0.00138	CbGeAlD
Pazopanib—STK16—brain—germ cell cancer	0.000136	0.00138	CbGeAlD
Pazopanib—MAP3K2—head—germ cell cancer	0.000136	0.00138	CbGeAlD
Pazopanib—Anorexia—Bleomycin—germ cell cancer	0.000136	0.00173	CcSEcCtD
Pazopanib—KIT—telencephalon—germ cell cancer	0.000135	0.00137	CbGeAlD
Pazopanib—Hypoaesthesia—Etoposide—germ cell cancer	0.000135	0.00171	CcSEcCtD
Pazopanib—LYN—brain—germ cell cancer	0.000135	0.00136	CbGeAlD
Pazopanib—RIOK2—brain—germ cell cancer	0.000134	0.00136	CbGeAlD
Pazopanib—FGFR3—brain—germ cell cancer	0.000134	0.00136	CbGeAlD
Pazopanib—Urinary tract disorder—Etoposide—germ cell cancer	0.000134	0.0017	CcSEcCtD
Pazopanib—Leukopenia—Ifosfamide—germ cell cancer	0.000134	0.0017	CcSEcCtD
Pazopanib—Abdominal pain—Vinblastine—germ cell cancer	0.000134	0.0017	CcSEcCtD
Pazopanib—TAOK3—medulla oblongata—germ cell cancer	0.000134	0.00135	CbGeAlD
Pazopanib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000133	0.00169	CcSEcCtD
Pazopanib—Oedema—Dactinomycin—germ cell cancer	0.000133	0.00169	CcSEcCtD
Pazopanib—Urethral disorder—Etoposide—germ cell cancer	0.000133	0.00169	CcSEcCtD
Pazopanib—MAP3K19—brain—germ cell cancer	0.000133	0.00134	CbGeAlD
Pazopanib—BMPR1B—brain—germ cell cancer	0.000133	0.00134	CbGeAlD
Pazopanib—Infection—Dactinomycin—germ cell cancer	0.000132	0.00168	CcSEcCtD
Pazopanib—FGFR2—female gonad—germ cell cancer	0.000132	0.00134	CbGeAlD
Pazopanib—PDGFRB—telencephalon—germ cell cancer	0.000132	0.00134	CbGeAlD
Pazopanib—STK16—lymph node—germ cell cancer	0.000132	0.00133	CbGeAlD
Pazopanib—MAP3K2—testis—germ cell cancer	0.000132	0.00133	CbGeAlD
Pazopanib—FLT1—adrenal gland—germ cell cancer	0.000131	0.00133	CbGeAlD
Pazopanib—Alopecia—Cisplatin—germ cell cancer	0.000131	0.00166	CcSEcCtD
Pazopanib—Hepatic failure—Methotrexate—germ cell cancer	0.000131	0.00166	CcSEcCtD
Pazopanib—Cough—Ifosfamide—germ cell cancer	0.000131	0.00166	CcSEcCtD
Pazopanib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00013	0.00166	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00013	0.00165	CcSEcCtD
Pazopanib—FGF1—endocrine gland—germ cell cancer	0.00013	0.00132	CbGeAlD
Pazopanib—EPHB6—adrenal gland—germ cell cancer	0.00013	0.00131	CbGeAlD
Pazopanib—RIOK2—lymph node—germ cell cancer	0.00013	0.00131	CbGeAlD
Pazopanib—FLT1—midbrain—germ cell cancer	0.00013	0.00131	CbGeAlD
Pazopanib—Hypertension—Ifosfamide—germ cell cancer	0.000129	0.00164	CcSEcCtD
Pazopanib—KIT—skin of body—germ cell cancer	0.000129	0.0013	CbGeAlD
Pazopanib—Malnutrition—Cisplatin—germ cell cancer	0.000129	0.00164	CcSEcCtD
Pazopanib—Erythema—Cisplatin—germ cell cancer	0.000129	0.00164	CcSEcCtD
Pazopanib—BMPR1B—lymph node—germ cell cancer	0.000128	0.0013	CbGeAlD
Pazopanib—FGF1—head—germ cell cancer	0.000128	0.0013	CbGeAlD
Pazopanib—Paraesthesia—Bleomycin—germ cell cancer	0.000128	0.00163	CcSEcCtD
Pazopanib—PIP4K2C—cerebellum—germ cell cancer	0.000128	0.0013	CbGeAlD
Pazopanib—KIT—decidua—germ cell cancer	0.000128	0.0013	CbGeAlD
Pazopanib—EPHB6—midbrain—germ cell cancer	0.000128	0.0013	CbGeAlD
Pazopanib—Dyspnoea—Bleomycin—germ cell cancer	0.000127	0.00162	CcSEcCtD
Pazopanib—Chest pain—Ifosfamide—germ cell cancer	0.000127	0.00162	CcSEcCtD
Pazopanib—Myalgia—Ifosfamide—germ cell cancer	0.000127	0.00162	CcSEcCtD
Pazopanib—Arthralgia—Ifosfamide—germ cell cancer	0.000127	0.00162	CcSEcCtD
Pazopanib—FGFR1—cerebellum—germ cell cancer	0.000127	0.00129	CbGeAlD
Pazopanib—Flatulence—Cisplatin—germ cell cancer	0.000127	0.00161	CcSEcCtD
Pazopanib—Anorexia—Dactinomycin—germ cell cancer	0.000127	0.00161	CcSEcCtD
Pazopanib—Eye disorder—Etoposide—germ cell cancer	0.000127	0.00161	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000126	0.0016	CcSEcCtD
Pazopanib—KDR—uterus—germ cell cancer	0.000126	0.00128	CbGeAlD
Pazopanib—FLT1—spinal cord—germ cell cancer	0.000126	0.00128	CbGeAlD
Pazopanib—PDGFRB—skin of body—germ cell cancer	0.000126	0.00127	CbGeAlD
Pazopanib—Cardiac disorder—Etoposide—germ cell cancer	0.000126	0.0016	CcSEcCtD
Pazopanib—Flushing—Etoposide—germ cell cancer	0.000126	0.0016	CcSEcCtD
Pazopanib—PDGFRB—decidua—germ cell cancer	0.000125	0.00127	CbGeAlD
Pazopanib—EPHB6—spinal cord—germ cell cancer	0.000125	0.00126	CbGeAlD
Pazopanib—STK10—adrenal gland—germ cell cancer	0.000124	0.00126	CbGeAlD
Pazopanib—CSF1R—gonad—germ cell cancer	0.000124	0.00126	CbGeAlD
Pazopanib—Decreased appetite—Bleomycin—germ cell cancer	0.000124	0.00158	CcSEcCtD
Pazopanib—KDR—pituitary gland—germ cell cancer	0.000124	0.00126	CbGeAlD
Pazopanib—MAP2K5—pituitary gland—germ cell cancer	0.000124	0.00126	CbGeAlD
Pazopanib—Muscle spasms—Cisplatin—germ cell cancer	0.000124	0.00157	CcSEcCtD
Pazopanib—FGF1—testis—germ cell cancer	0.000124	0.00125	CbGeAlD
Pazopanib—TAOK3—adrenal gland—germ cell cancer	0.000124	0.00125	CbGeAlD
Pazopanib—CSF1R—uterus—germ cell cancer	0.000123	0.00125	CbGeAlD
Pazopanib—LCK—testis—germ cell cancer	0.000123	0.00125	CbGeAlD
Pazopanib—Angiopathy—Etoposide—germ cell cancer	0.000123	0.00156	CcSEcCtD
Pazopanib—PDGFRA—adrenal gland—germ cell cancer	0.000123	0.00124	CbGeAlD
Pazopanib—FGFR2—endocrine gland—germ cell cancer	0.000123	0.00124	CbGeAlD
Pazopanib—FLT1—female gonad—germ cell cancer	0.000122	0.00124	CbGeAlD
Pazopanib—Mediastinal disorder—Etoposide—germ cell cancer	0.000122	0.00155	CcSEcCtD
Pazopanib—TAOK3—midbrain—germ cell cancer	0.000122	0.00124	CbGeAlD
Pazopanib—Pain—Bleomycin—germ cell cancer	0.000122	0.00155	CcSEcCtD
Pazopanib—Oedema—Ifosfamide—germ cell cancer	0.000122	0.00155	CcSEcCtD
Pazopanib—Chills—Etoposide—germ cell cancer	0.000122	0.00155	CcSEcCtD
Pazopanib—Vision blurred—Cisplatin—germ cell cancer	0.000122	0.00154	CcSEcCtD
Pazopanib—MAP3K2—cerebellum—germ cell cancer	0.000122	0.00123	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000121	0.00154	CcSEcCtD
Pazopanib—Asthenia—Vinblastine—germ cell cancer	0.000121	0.00154	CcSEcCtD
Pazopanib—Infection—Ifosfamide—germ cell cancer	0.000121	0.00154	CcSEcCtD
Pazopanib—FGFR2—head—germ cell cancer	0.000121	0.00123	CbGeAlD
Pazopanib—CSF1R—pituitary gland—germ cell cancer	0.000121	0.00123	CbGeAlD
Pazopanib—EPHB6—female gonad—germ cell cancer	0.000121	0.00122	CbGeAlD
Pazopanib—STK36—brain—germ cell cancer	0.00012	0.00122	CbGeAlD
Pazopanib—STK10—bone marrow—germ cell cancer	0.00012	0.00122	CbGeAlD
Pazopanib—Alopecia—Etoposide—germ cell cancer	0.00012	0.00152	CcSEcCtD
Pazopanib—Lethargy—Methotrexate—germ cell cancer	0.00012	0.00152	CcSEcCtD
Pazopanib—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00012	0.00152	CcSEcCtD
Pazopanib—KDR—medulla oblongata—germ cell cancer	0.00012	0.00121	CbGeAlD
Pazopanib—MAP2K5—medulla oblongata—germ cell cancer	0.00012	0.00121	CbGeAlD
Pazopanib—Nervous system disorder—Ifosfamide—germ cell cancer	0.00012	0.00152	CcSEcCtD
Pazopanib—TAOK3—bone marrow—germ cell cancer	0.00012	0.00121	CbGeAlD
Pazopanib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00012	0.00152	CcSEcCtD
Pazopanib—Anaemia—Cisplatin—germ cell cancer	0.000119	0.00151	CcSEcCtD
Pazopanib—TAOK3—spinal cord—germ cell cancer	0.000119	0.00121	CbGeAlD
Pazopanib—PI4KB—brain—germ cell cancer	0.000119	0.0012	CbGeAlD
Pazopanib—Skin disorder—Ifosfamide—germ cell cancer	0.000119	0.0015	CcSEcCtD
Pazopanib—PDGFRA—spinal cord—germ cell cancer	0.000118	0.0012	CbGeAlD
Pazopanib—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000118	0.0015	CcSEcCtD
Pazopanib—FGFR2—testis—germ cell cancer	0.000117	0.00118	CbGeAlD
Pazopanib—CSF1R—medulla oblongata—germ cell cancer	0.000117	0.00118	CbGeAlD
Pazopanib—LIMK2—brain—germ cell cancer	0.000116	0.00118	CbGeAlD
Pazopanib—STK36—lymph node—germ cell cancer	0.000116	0.00118	CbGeAlD
Pazopanib—Anorexia—Ifosfamide—germ cell cancer	0.000116	0.00148	CcSEcCtD
Pazopanib—STK10—female gonad—germ cell cancer	0.000116	0.00117	CbGeAlD
Pazopanib—Decreased appetite—Dactinomycin—germ cell cancer	0.000116	0.00147	CcSEcCtD
Pazopanib—Diarrhoea—Vinblastine—germ cell cancer	0.000116	0.00147	CcSEcCtD
Pazopanib—Dysgeusia—Etoposide—germ cell cancer	0.000116	0.00147	CcSEcCtD
Pazopanib—Leukopenia—Cisplatin—germ cell cancer	0.000115	0.00146	CcSEcCtD
Pazopanib—TAOK3—female gonad—germ cell cancer	0.000115	0.00117	CbGeAlD
Pazopanib—Fatigue—Dactinomycin—germ cell cancer	0.000115	0.00146	CcSEcCtD
Pazopanib—PI4KB—lymph node—germ cell cancer	0.000115	0.00116	CbGeAlD
Pazopanib—PDGFRA—female gonad—germ cell cancer	0.000115	0.00116	CbGeAlD
Pazopanib—FGF1—cerebellum—germ cell cancer	0.000114	0.00116	CbGeAlD
Pazopanib—Pain—Dactinomycin—germ cell cancer	0.000114	0.00145	CcSEcCtD
Pazopanib—FLT1—endocrine gland—germ cell cancer	0.000114	0.00115	CbGeAlD
Pazopanib—Muscle spasms—Etoposide—germ cell cancer	0.000114	0.00144	CcSEcCtD
Pazopanib—KIT—gonad—germ cell cancer	0.000113	0.00114	CbGeAlD
Pazopanib—LIMK2—lymph node—germ cell cancer	0.000113	0.00114	CbGeAlD
Pazopanib—FLT1—head—germ cell cancer	0.000112	0.00114	CbGeAlD
Pazopanib—KIT—uterus—germ cell cancer	0.000112	0.00113	CbGeAlD
Pazopanib—Dizziness—Vinblastine—germ cell cancer	0.000112	0.00142	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000111	0.00141	CcSEcCtD
Pazopanib—EPHB6—head—germ cell cancer	0.000111	0.00112	CbGeAlD
Pazopanib—KDR—adrenal gland—germ cell cancer	0.000111	0.00112	CbGeAlD
Pazopanib—MAP2K5—adrenal gland—germ cell cancer	0.000111	0.00112	CbGeAlD
Pazopanib—PDGFRB—gonad—germ cell cancer	0.00011	0.00111	CbGeAlD
Pazopanib—KIT—pituitary gland—germ cell cancer	0.00011	0.00111	CbGeAlD
Pazopanib—Myalgia—Cisplatin—germ cell cancer	0.00011	0.00139	CcSEcCtD
Pazopanib—Paraesthesia—Ifosfamide—germ cell cancer	0.00011	0.00139	CcSEcCtD
Pazopanib—KDR—midbrain—germ cell cancer	0.000109	0.00111	CbGeAlD
Pazopanib—MAP2K5—midbrain—germ cell cancer	0.000109	0.00111	CbGeAlD
Pazopanib—PDGFRB—uterus—germ cell cancer	0.000109	0.00111	CbGeAlD
Pazopanib—Anaemia—Etoposide—germ cell cancer	0.000109	0.00139	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000109	0.00138	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000109	0.00138	CcSEcCtD
Pazopanib—Dyspnoea—Ifosfamide—germ cell cancer	0.000109	0.00138	CcSEcCtD
Pazopanib—Somnolence—Ifosfamide—germ cell cancer	0.000109	0.00138	CcSEcCtD
Pazopanib—FLT1—testis—germ cell cancer	0.000108	0.0011	CbGeAlD
Pazopanib—Liver function test abnormal—Methotrexate—germ cell cancer	0.000108	0.00138	CcSEcCtD
Pazopanib—CSF1R—adrenal gland—germ cell cancer	0.000108	0.0011	CbGeAlD
Pazopanib—FGFR2—cerebellum—germ cell cancer	0.000108	0.00109	CbGeAlD
Pazopanib—STK10—endocrine gland—germ cell cancer	0.000108	0.00109	CbGeAlD
Pazopanib—Vomiting—Vinblastine—germ cell cancer	0.000108	0.00136	CcSEcCtD
Pazopanib—PDGFRB—pituitary gland—germ cell cancer	0.000107	0.00109	CbGeAlD
Pazopanib—KDR—bone marrow—germ cell cancer	0.000107	0.00109	CbGeAlD
Pazopanib—TAOK3—endocrine gland—germ cell cancer	0.000107	0.00109	CbGeAlD
Pazopanib—EPHB6—testis—germ cell cancer	0.000107	0.00109	CbGeAlD
Pazopanib—CSF1R—midbrain—germ cell cancer	0.000107	0.00108	CbGeAlD
Pazopanib—KDR—spinal cord—germ cell cancer	0.000107	0.00108	CbGeAlD
Pazopanib—MAP2K5—spinal cord—germ cell cancer	0.000107	0.00108	CbGeAlD
Pazopanib—PDGFRA—endocrine gland—germ cell cancer	0.000107	0.00108	CbGeAlD
Pazopanib—STK10—head—germ cell cancer	0.000106	0.00108	CbGeAlD
Pazopanib—Breast disorder—Methotrexate—germ cell cancer	0.000106	0.00135	CcSEcCtD
Pazopanib—KIT—medulla oblongata—germ cell cancer	0.000106	0.00107	CbGeAlD
Pazopanib—Decreased appetite—Ifosfamide—germ cell cancer	0.000106	0.00135	CcSEcCtD
Pazopanib—Headache—Vinblastine—germ cell cancer	0.000106	0.00134	CcSEcCtD
Pazopanib—TAOK3—head—germ cell cancer	0.000106	0.00107	CbGeAlD
Pazopanib—Leukopenia—Etoposide—germ cell cancer	0.000106	0.00134	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000105	0.00134	CcSEcCtD
Pazopanib—Abdominal pain—Dactinomycin—germ cell cancer	0.000105	0.00134	CcSEcCtD
Pazopanib—PDGFRA—head—germ cell cancer	0.000105	0.00107	CbGeAlD
Pazopanib—Fatigue—Ifosfamide—germ cell cancer	0.000105	0.00134	CcSEcCtD
Pazopanib—Oedema—Cisplatin—germ cell cancer	0.000105	0.00134	CcSEcCtD
Pazopanib—CSF1R—bone marrow—germ cell cancer	0.000105	0.00106	CbGeAlD
Pazopanib—FLT4—brain—germ cell cancer	0.000105	0.00106	CbGeAlD
Pazopanib—Infection—Cisplatin—germ cell cancer	0.000105	0.00133	CcSEcCtD
Pazopanib—Pain—Ifosfamide—germ cell cancer	0.000104	0.00132	CcSEcCtD
Pazopanib—CSF1R—spinal cord—germ cell cancer	0.000104	0.00106	CbGeAlD
Pazopanib—PIP4K2C—brain—germ cell cancer	0.000104	0.00105	CbGeAlD
Pazopanib—Loss of consciousness—Etoposide—germ cell cancer	0.000104	0.00132	CcSEcCtD
Pazopanib—PDGFRB—medulla oblongata—germ cell cancer	0.000104	0.00105	CbGeAlD
Pazopanib—KDR—female gonad—germ cell cancer	0.000103	0.00105	CbGeAlD
Pazopanib—MAP2K5—female gonad—germ cell cancer	0.000103	0.00105	CbGeAlD
Pazopanib—FGFR1—brain—germ cell cancer	0.000103	0.00105	CbGeAlD
Pazopanib—Nervous system disorder—Cisplatin—germ cell cancer	0.000103	0.00131	CcSEcCtD
Pazopanib—Cough—Etoposide—germ cell cancer	0.000103	0.00131	CcSEcCtD
Pazopanib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000103	0.00131	CcSEcCtD
Pazopanib—STK10—testis—germ cell cancer	0.000103	0.00104	CbGeAlD
Pazopanib—Asthenia—Bleomycin—germ cell cancer	0.000102	0.0013	CcSEcCtD
Pazopanib—TAOK3—testis—germ cell cancer	0.000102	0.00104	CbGeAlD
Pazopanib—Skin disorder—Cisplatin—germ cell cancer	0.000102	0.0013	CcSEcCtD
Pazopanib—Hypertension—Etoposide—germ cell cancer	0.000102	0.00129	CcSEcCtD
Pazopanib—Hyperhidrosis—Cisplatin—germ cell cancer	0.000102	0.00129	CcSEcCtD
Pazopanib—UGT1A1—endocrine gland—germ cell cancer	0.000102	0.00103	CbGeAlD
Pazopanib—PDGFRA—testis—germ cell cancer	0.000102	0.00103	CbGeAlD
Pazopanib—FLT4—lymph node—germ cell cancer	0.000101	0.00102	CbGeAlD
Pazopanib—Pruritus—Bleomycin—germ cell cancer	0.000101	0.00128	CcSEcCtD
Pazopanib—CSF1R—female gonad—germ cell cancer	0.000101	0.00102	CbGeAlD
Pazopanib—PIP4K2C—lymph node—germ cell cancer	0.000101	0.00102	CbGeAlD
Pazopanib—Chest pain—Etoposide—germ cell cancer	0.000101	0.00128	CcSEcCtD
Pazopanib—Nausea—Vinblastine—germ cell cancer	0.0001	0.00127	CcSEcCtD
Pazopanib—Anorexia—Cisplatin—germ cell cancer	0.0001	0.00127	CcSEcCtD
Pazopanib—FLT1—cerebellum—germ cell cancer	0.0001	0.00101	CbGeAlD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	9.99e-05	0.00127	CcSEcCtD
Pazopanib—Gastrointestinal pain—Ifosfamide—germ cell cancer	9.98e-05	0.00127	CcSEcCtD
Pazopanib—FGFR1—lymph node—germ cell cancer	9.98e-05	0.00101	CbGeAlD
Pazopanib—Pancreatitis—Methotrexate—germ cell cancer	9.96e-05	0.00126	CcSEcCtD
Pazopanib—EPHB6—cerebellum—germ cell cancer	9.91e-05	0.001	CbGeAlD
Pazopanib—MAP3K2—brain—germ cell cancer	9.87e-05	0.000999	CbGeAlD
Pazopanib—KIT—adrenal gland—germ cell cancer	9.83e-05	0.000995	CbGeAlD
Pazopanib—KIT—midbrain—germ cell cancer	9.7e-05	0.000982	CbGeAlD
Pazopanib—Abdominal pain—Ifosfamide—germ cell cancer	9.65e-05	0.00122	CcSEcCtD
Pazopanib—KDR—endocrine gland—germ cell cancer	9.62e-05	0.000973	CbGeAlD
Pazopanib—MAP2K5—endocrine gland—germ cell cancer	9.62e-05	0.000973	CbGeAlD
Pazopanib—PDGFRB—adrenal gland—germ cell cancer	9.6e-05	0.000971	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	9.59e-05	0.00122	CcSEcCtD
Pazopanib—Infection—Etoposide—germ cell cancer	9.58e-05	0.00122	CcSEcCtD
Pazopanib—Asthenia—Dactinomycin—germ cell cancer	9.56e-05	0.00121	CcSEcCtD
Pazopanib—MAP3K2—lymph node—germ cell cancer	9.54e-05	0.000965	CbGeAlD
Pazopanib—KIT—bone marrow—germ cell cancer	9.51e-05	0.000962	CbGeAlD
Pazopanib—Neutropenia—Methotrexate—germ cell cancer	9.5e-05	0.0012	CcSEcCtD
Pazopanib—KDR—head—germ cell cancer	9.49e-05	0.000961	CbGeAlD
Pazopanib—MAP2K5—head—germ cell cancer	9.49e-05	0.000961	CbGeAlD
Pazopanib—STK10—cerebellum—germ cell cancer	9.49e-05	0.00096	CbGeAlD
Pazopanib—PDGFRB—midbrain—germ cell cancer	9.48e-05	0.000959	CbGeAlD
Pazopanib—KIT—spinal cord—germ cell cancer	9.47e-05	0.000958	CbGeAlD
Pazopanib—Paraesthesia—Cisplatin—germ cell cancer	9.45e-05	0.0012	CcSEcCtD
Pazopanib—TAOK3—cerebellum—germ cell cancer	9.45e-05	0.000956	CbGeAlD
Pazopanib—ABCG2—trigeminal ganglion—germ cell cancer	9.44e-05	0.000956	CbGeAlD
Pazopanib—Thrombocytopenia—Etoposide—germ cell cancer	9.44e-05	0.0012	CcSEcCtD
Pazopanib—PDGFRA—cerebellum—germ cell cancer	9.39e-05	0.00095	CbGeAlD
Pazopanib—CSF1R—endocrine gland—germ cell cancer	9.39e-05	0.00095	CbGeAlD
Pazopanib—Dyspnoea—Cisplatin—germ cell cancer	9.38e-05	0.00119	CcSEcCtD
Pazopanib—Skin disorder—Etoposide—germ cell cancer	9.36e-05	0.00119	CcSEcCtD
Pazopanib—Hyperhidrosis—Etoposide—germ cell cancer	9.32e-05	0.00118	CcSEcCtD
Pazopanib—FGF1—brain—germ cell cancer	9.3e-05	0.000941	CbGeAlD
Pazopanib—PDGFRB—bone marrow—germ cell cancer	9.29e-05	0.00094	CbGeAlD
Pazopanib—Photosensitivity reaction—Methotrexate—germ cell cancer	9.27e-05	0.00118	CcSEcCtD
Pazopanib—CSF1R—head—germ cell cancer	9.27e-05	0.000938	CbGeAlD
Pazopanib—PDGFRB—spinal cord—germ cell cancer	9.25e-05	0.000936	CbGeAlD
Pazopanib—Anorexia—Etoposide—germ cell cancer	9.19e-05	0.00117	CcSEcCtD
Pazopanib—KDR—testis—germ cell cancer	9.17e-05	0.000928	CbGeAlD
Pazopanib—MAP2K5—testis—germ cell cancer	9.17e-05	0.000928	CbGeAlD
Pazopanib—KIT—female gonad—germ cell cancer	9.16e-05	0.000927	CbGeAlD
Pazopanib—Decreased appetite—Cisplatin—germ cell cancer	9.15e-05	0.00116	CcSEcCtD
Pazopanib—Diarrhoea—Dactinomycin—germ cell cancer	9.11e-05	0.00116	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Cisplatin—germ cell cancer	9.09e-05	0.00115	CcSEcCtD
Pazopanib—Vomiting—Bleomycin—germ cell cancer	9.08e-05	0.00115	CcSEcCtD
Pazopanib—Infestation—Methotrexate—germ cell cancer	9.05e-05	0.00115	CcSEcCtD
Pazopanib—Infestation NOS—Methotrexate—germ cell cancer	9.05e-05	0.00115	CcSEcCtD
Pazopanib—Rash—Bleomycin—germ cell cancer	9.01e-05	0.00114	CcSEcCtD
Pazopanib—Pain—Cisplatin—germ cell cancer	9e-05	0.00114	CcSEcCtD
Pazopanib—Dermatitis—Bleomycin—germ cell cancer	9e-05	0.00114	CcSEcCtD
Pazopanib—FGF1—lymph node—germ cell cancer	8.98e-05	0.000909	CbGeAlD
Pazopanib—CSF1R—testis—germ cell cancer	8.95e-05	0.000906	CbGeAlD
Pazopanib—PDGFRB—female gonad—germ cell cancer	8.95e-05	0.000906	CbGeAlD
Pazopanib—LCK—lymph node—germ cell cancer	8.93e-05	0.000904	CbGeAlD
Pazopanib—Stomatitis—Methotrexate—germ cell cancer	8.83e-05	0.00112	CcSEcCtD
Pazopanib—FGFR2—brain—germ cell cancer	8.78e-05	0.000889	CbGeAlD
Pazopanib—Asthenia—Ifosfamide—germ cell cancer	8.76e-05	0.00111	CcSEcCtD
Pazopanib—Paraesthesia—Etoposide—germ cell cancer	8.66e-05	0.0011	CcSEcCtD
Pazopanib—Pruritus—Ifosfamide—germ cell cancer	8.64e-05	0.0011	CcSEcCtD
Pazopanib—Haematuria—Methotrexate—germ cell cancer	8.63e-05	0.0011	CcSEcCtD
Pazopanib—Dyspnoea—Etoposide—germ cell cancer	8.6e-05	0.00109	CcSEcCtD
Pazopanib—Somnolence—Etoposide—germ cell cancer	8.57e-05	0.00109	CcSEcCtD
Pazopanib—Hepatobiliary disease—Methotrexate—germ cell cancer	8.56e-05	0.00109	CcSEcCtD
Pazopanib—Epistaxis—Methotrexate—germ cell cancer	8.54e-05	0.00108	CcSEcCtD
Pazopanib—KIT—endocrine gland—germ cell cancer	8.52e-05	0.000863	CbGeAlD
Pazopanib—Nausea—Bleomycin—germ cell cancer	8.48e-05	0.00108	CcSEcCtD
Pazopanib—KDR—cerebellum—germ cell cancer	8.47e-05	0.000857	CbGeAlD
Pazopanib—MAP2K5—cerebellum—germ cell cancer	8.47e-05	0.000857	CbGeAlD
Pazopanib—Vomiting—Dactinomycin—germ cell cancer	8.47e-05	0.00107	CcSEcCtD
Pazopanib—SLCO1B1—endocrine gland—germ cell cancer	8.46e-05	0.000856	CbGeAlD
Pazopanib—KIT—head—germ cell cancer	8.41e-05	0.000851	CbGeAlD
Pazopanib—Rash—Dactinomycin—germ cell cancer	8.4e-05	0.00107	CcSEcCtD
Pazopanib—Decreased appetite—Etoposide—germ cell cancer	8.38e-05	0.00106	CcSEcCtD
Pazopanib—Diarrhoea—Ifosfamide—germ cell cancer	8.35e-05	0.00106	CcSEcCtD
Pazopanib—PDGFRB—endocrine gland—germ cell cancer	8.32e-05	0.000842	CbGeAlD
Pazopanib—Gastrointestinal disorder—Etoposide—germ cell cancer	8.32e-05	0.00106	CcSEcCtD
Pazopanib—Fatigue—Etoposide—germ cell cancer	8.31e-05	0.00105	CcSEcCtD
Pazopanib—CSF1R—cerebellum—germ cell cancer	8.27e-05	0.000837	CbGeAlD
Pazopanib—Pain—Etoposide—germ cell cancer	8.24e-05	0.00105	CcSEcCtD
Pazopanib—PDGFRB—head—germ cell cancer	8.22e-05	0.000832	CbGeAlD
Pazopanib—Haemoglobin—Methotrexate—germ cell cancer	8.17e-05	0.00104	CcSEcCtD
Pazopanib—FLT1—brain—germ cell cancer	8.14e-05	0.000824	CbGeAlD
Pazopanib—Haemorrhage—Methotrexate—germ cell cancer	8.13e-05	0.00103	CcSEcCtD
Pazopanib—KIT—testis—germ cell cancer	8.13e-05	0.000823	CbGeAlD
Pazopanib—Dizziness—Ifosfamide—germ cell cancer	8.07e-05	0.00102	CcSEcCtD
Pazopanib—EPHB6—brain—germ cell cancer	8.05e-05	0.000814	CbGeAlD
Pazopanib—Urinary tract disorder—Methotrexate—germ cell cancer	8.03e-05	0.00102	CcSEcCtD
Pazopanib—Urethral disorder—Methotrexate—germ cell cancer	7.97e-05	0.00101	CcSEcCtD
Pazopanib—PDGFRB—testis—germ cell cancer	7.94e-05	0.000803	CbGeAlD
Pazopanib—Nausea—Dactinomycin—germ cell cancer	7.91e-05	0.001	CcSEcCtD
Pazopanib—Gastrointestinal pain—Etoposide—germ cell cancer	7.88e-05	0.001	CcSEcCtD
Pazopanib—FLT1—lymph node—germ cell cancer	7.86e-05	0.000796	CbGeAlD
Pazopanib—EPHB6—lymph node—germ cell cancer	7.77e-05	0.000787	CbGeAlD
Pazopanib—Vomiting—Ifosfamide—germ cell cancer	7.76e-05	0.000985	CcSEcCtD
Pazopanib—STK10—brain—germ cell cancer	7.7e-05	0.00078	CbGeAlD
Pazopanib—Rash—Ifosfamide—germ cell cancer	7.7e-05	0.000977	CcSEcCtD
Pazopanib—Dermatitis—Ifosfamide—germ cell cancer	7.69e-05	0.000976	CcSEcCtD
Pazopanib—TAOK3—brain—germ cell cancer	7.68e-05	0.000777	CbGeAlD
Pazopanib—PDGFRA—brain—germ cell cancer	7.63e-05	0.000772	CbGeAlD
Pazopanib—Abdominal pain—Etoposide—germ cell cancer	7.62e-05	0.000967	CcSEcCtD
Pazopanib—Eye disorder—Methotrexate—germ cell cancer	7.6e-05	0.000964	CcSEcCtD
Pazopanib—Asthenia—Cisplatin—germ cell cancer	7.55e-05	0.000958	CcSEcCtD
Pazopanib—Cardiac disorder—Methotrexate—germ cell cancer	7.54e-05	0.000957	CcSEcCtD
Pazopanib—ABCB1—blood vessel—germ cell cancer	7.54e-05	0.000763	CbGeAlD
Pazopanib—KIT—cerebellum—germ cell cancer	7.51e-05	0.00076	CbGeAlD
Pazopanib—STK10—lymph node—germ cell cancer	7.44e-05	0.000753	CbGeAlD
Pazopanib—ABCG2—telencephalon—germ cell cancer	7.42e-05	0.000751	CbGeAlD
Pazopanib—TAOK3—lymph node—germ cell cancer	7.42e-05	0.000751	CbGeAlD
Pazopanib—Angiopathy—Methotrexate—germ cell cancer	7.37e-05	0.000936	CcSEcCtD
Pazopanib—PDGFRA—lymph node—germ cell cancer	7.37e-05	0.000746	CbGeAlD
Pazopanib—PDGFRB—cerebellum—germ cell cancer	7.33e-05	0.000742	CbGeAlD
Pazopanib—Mediastinal disorder—Methotrexate—germ cell cancer	7.33e-05	0.00093	CcSEcCtD
Pazopanib—Chills—Methotrexate—germ cell cancer	7.29e-05	0.000925	CcSEcCtD
Pazopanib—Nausea—Ifosfamide—germ cell cancer	7.25e-05	0.00092	CcSEcCtD
Pazopanib—Diarrhoea—Cisplatin—germ cell cancer	7.2e-05	0.000914	CcSEcCtD
Pazopanib—Alopecia—Methotrexate—germ cell cancer	7.18e-05	0.000911	CcSEcCtD
Pazopanib—Mental disorder—Methotrexate—germ cell cancer	7.12e-05	0.000904	CcSEcCtD
Pazopanib—Erythema—Methotrexate—germ cell cancer	7.08e-05	0.000898	CcSEcCtD
Pazopanib—Malnutrition—Methotrexate—germ cell cancer	7.08e-05	0.000898	CcSEcCtD
Pazopanib—ABCG2—decidua—germ cell cancer	7.03e-05	0.000711	CbGeAlD
Pazopanib—Dysgeusia—Methotrexate—germ cell cancer	6.93e-05	0.000879	CcSEcCtD
Pazopanib—Asthenia—Etoposide—germ cell cancer	6.92e-05	0.000878	CcSEcCtD
Pazopanib—KDR—brain—germ cell cancer	6.88e-05	0.000696	CbGeAlD
Pazopanib—MAP2K5—brain—germ cell cancer	6.88e-05	0.000696	CbGeAlD
Pazopanib—Pruritus—Etoposide—germ cell cancer	6.82e-05	0.000866	CcSEcCtD
Pazopanib—CSF1R—brain—germ cell cancer	6.71e-05	0.00068	CbGeAlD
Pazopanib—Vomiting—Cisplatin—germ cell cancer	6.69e-05	0.000849	CcSEcCtD
Pazopanib—Vision blurred—Methotrexate—germ cell cancer	6.67e-05	0.000846	CcSEcCtD
Pazopanib—KDR—lymph node—germ cell cancer	6.65e-05	0.000673	CbGeAlD
Pazopanib—MAP2K5—lymph node—germ cell cancer	6.65e-05	0.000673	CbGeAlD
Pazopanib—Rash—Cisplatin—germ cell cancer	6.64e-05	0.000842	CcSEcCtD
Pazopanib—Dermatitis—Cisplatin—germ cell cancer	6.63e-05	0.000841	CcSEcCtD
Pazopanib—Diarrhoea—Etoposide—germ cell cancer	6.6e-05	0.000837	CcSEcCtD
Pazopanib—Anaemia—Methotrexate—germ cell cancer	6.54e-05	0.00083	CcSEcCtD
Pazopanib—CSF1R—lymph node—germ cell cancer	6.49e-05	0.000657	CbGeAlD
Pazopanib—Dizziness—Etoposide—germ cell cancer	6.38e-05	0.000809	CcSEcCtD
Pazopanib—Leukopenia—Methotrexate—germ cell cancer	6.33e-05	0.000804	CcSEcCtD
Pazopanib—Nausea—Cisplatin—germ cell cancer	6.25e-05	0.000793	CcSEcCtD
Pazopanib—CYP2C8—pituitary gland—germ cell cancer	6.21e-05	0.000629	CbGeAlD
Pazopanib—Cough—Methotrexate—germ cell cancer	6.17e-05	0.000784	CcSEcCtD
Pazopanib—ABCG2—uterus—germ cell cancer	6.15e-05	0.000622	CbGeAlD
Pazopanib—Vomiting—Etoposide—germ cell cancer	6.13e-05	0.000778	CcSEcCtD
Pazopanib—KIT—brain—germ cell cancer	6.1e-05	0.000617	CbGeAlD
Pazopanib—Rash—Etoposide—germ cell cancer	6.08e-05	0.000771	CcSEcCtD
Pazopanib—Dermatitis—Etoposide—germ cell cancer	6.07e-05	0.000771	CcSEcCtD
Pazopanib—Headache—Etoposide—germ cell cancer	6.04e-05	0.000766	CcSEcCtD
Pazopanib—ABCG2—pituitary gland—germ cell cancer	6.04e-05	0.000611	CbGeAlD
Pazopanib—Myalgia—Methotrexate—germ cell cancer	6.02e-05	0.000764	CcSEcCtD
Pazopanib—Chest pain—Methotrexate—germ cell cancer	6.02e-05	0.000764	CcSEcCtD
Pazopanib—Arthralgia—Methotrexate—germ cell cancer	6.02e-05	0.000764	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	5.98e-05	0.000759	CcSEcCtD
Pazopanib—PDGFRB—brain—germ cell cancer	5.96e-05	0.000603	CbGeAlD
Pazopanib—KIT—lymph node—germ cell cancer	5.89e-05	0.000596	CbGeAlD
Pazopanib—ABCG2—medulla oblongata—germ cell cancer	5.83e-05	0.00059	CbGeAlD
Pazopanib—PDGFRB—lymph node—germ cell cancer	5.75e-05	0.000582	CbGeAlD
Pazopanib—Infection—Methotrexate—germ cell cancer	5.74e-05	0.000728	CcSEcCtD
Pazopanib—CYP2D6—brainstem—germ cell cancer	5.73e-05	0.00058	CbGeAlD
Pazopanib—Nausea—Etoposide—germ cell cancer	5.73e-05	0.000727	CcSEcCtD
Pazopanib—Nervous system disorder—Methotrexate—germ cell cancer	5.66e-05	0.000719	CcSEcCtD
Pazopanib—Thrombocytopenia—Methotrexate—germ cell cancer	5.65e-05	0.000717	CcSEcCtD
Pazopanib—Skin disorder—Methotrexate—germ cell cancer	5.61e-05	0.000712	CcSEcCtD
Pazopanib—Hyperhidrosis—Methotrexate—germ cell cancer	5.58e-05	0.000708	CcSEcCtD
Pazopanib—Anorexia—Methotrexate—germ cell cancer	5.5e-05	0.000699	CcSEcCtD
Pazopanib—ABCG2—adrenal gland—germ cell cancer	5.4e-05	0.000546	CbGeAlD
Pazopanib—ABCG2—midbrain—germ cell cancer	5.33e-05	0.000539	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	5.26e-05	0.000668	CcSEcCtD
Pazopanib—Insomnia—Methotrexate—germ cell cancer	5.22e-05	0.000663	CcSEcCtD
Pazopanib—ABCG2—bone marrow—germ cell cancer	5.22e-05	0.000528	CbGeAlD
Pazopanib—ABCG2—spinal cord—germ cell cancer	5.2e-05	0.000526	CbGeAlD
Pazopanib—Paraesthesia—Methotrexate—germ cell cancer	5.19e-05	0.000658	CcSEcCtD
Pazopanib—Dyspnoea—Methotrexate—germ cell cancer	5.15e-05	0.000653	CcSEcCtD
Pazopanib—Somnolence—Methotrexate—germ cell cancer	5.13e-05	0.000651	CcSEcCtD
Pazopanib—CYP2D6—telencephalon—germ cell cancer	5.08e-05	0.000515	CbGeAlD
Pazopanib—Dyspepsia—Methotrexate—germ cell cancer	5.08e-05	0.000645	CcSEcCtD
Pazopanib—ABCG2—female gonad—germ cell cancer	5.03e-05	0.000509	CbGeAlD
Pazopanib—Decreased appetite—Methotrexate—germ cell cancer	5.02e-05	0.000637	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Methotrexate—germ cell cancer	4.99e-05	0.000633	CcSEcCtD
Pazopanib—Fatigue—Methotrexate—germ cell cancer	4.98e-05	0.000632	CcSEcCtD
Pazopanib—Pain—Methotrexate—germ cell cancer	4.94e-05	0.000627	CcSEcCtD
Pazopanib—CYP2C8—endocrine gland—germ cell cancer	4.81e-05	0.000487	CbGeAlD
Pazopanib—Gastrointestinal pain—Methotrexate—germ cell cancer	4.72e-05	0.000599	CcSEcCtD
Pazopanib—ABCB1—trigeminal ganglion—germ cell cancer	4.66e-05	0.000471	CbGeAlD
Pazopanib—CYP2C8—testis—germ cell cancer	4.59e-05	0.000464	CbGeAlD
Pazopanib—Abdominal pain—Methotrexate—germ cell cancer	4.57e-05	0.000579	CcSEcCtD
Pazopanib—CYP1A2—endocrine gland—germ cell cancer	4.5e-05	0.000456	CbGeAlD
Pazopanib—ABCB1—embryo—germ cell cancer	4.5e-05	0.000455	CbGeAlD
Pazopanib—ABCG2—testis—germ cell cancer	4.46e-05	0.000452	CbGeAlD
Pazopanib—Asthenia—Methotrexate—germ cell cancer	4.14e-05	0.000526	CcSEcCtD
Pazopanib—ABCG2—cerebellum—germ cell cancer	4.12e-05	0.000417	CbGeAlD
Pazopanib—Pruritus—Methotrexate—germ cell cancer	4.09e-05	0.000518	CcSEcCtD
Pazopanib—ABCB1—retina—germ cell cancer	3.98e-05	0.000402	CbGeAlD
Pazopanib—Diarrhoea—Methotrexate—germ cell cancer	3.95e-05	0.000501	CcSEcCtD
Pazopanib—Dizziness—Methotrexate—germ cell cancer	3.82e-05	0.000485	CcSEcCtD
Pazopanib—Vomiting—Methotrexate—germ cell cancer	3.67e-05	0.000466	CcSEcCtD
Pazopanib—ABCB1—telencephalon—germ cell cancer	3.66e-05	0.00037	CbGeAlD
Pazopanib—Rash—Methotrexate—germ cell cancer	3.64e-05	0.000462	CcSEcCtD
Pazopanib—Dermatitis—Methotrexate—germ cell cancer	3.64e-05	0.000462	CcSEcCtD
Pazopanib—Headache—Methotrexate—germ cell cancer	3.62e-05	0.000459	CcSEcCtD
Pazopanib—ABCB1—decidua—germ cell cancer	3.47e-05	0.000351	CbGeAlD
Pazopanib—CYP2D6—female gonad—germ cell cancer	3.45e-05	0.000349	CbGeAlD
Pazopanib—CYP2C8—brain—germ cell cancer	3.44e-05	0.000348	CbGeAlD
Pazopanib—Nausea—Methotrexate—germ cell cancer	3.43e-05	0.000435	CcSEcCtD
Pazopanib—ABCG2—brain—germ cell cancer	3.35e-05	0.000339	CbGeAlD
Pazopanib—CYP3A4—endocrine gland—germ cell cancer	3.26e-05	0.00033	CbGeAlD
Pazopanib—ABCG2—lymph node—germ cell cancer	3.23e-05	0.000327	CbGeAlD
Pazopanib—CYP2D6—endocrine gland—germ cell cancer	3.21e-05	0.000325	CbGeAlD
Pazopanib—CYP2D6—head—germ cell cancer	3.17e-05	0.00032	CbGeAlD
Pazopanib—CYP2D6—testis—germ cell cancer	3.06e-05	0.00031	CbGeAlD
Pazopanib—ABCB1—gonad—germ cell cancer	3.05e-05	0.000309	CbGeAlD
Pazopanib—ABCB1—uterus—germ cell cancer	3.03e-05	0.000307	CbGeAlD
Pazopanib—ABCB1—pituitary gland—germ cell cancer	2.98e-05	0.000301	CbGeAlD
Pazopanib—ABCB1—medulla oblongata—germ cell cancer	2.87e-05	0.000291	CbGeAlD
Pazopanib—CYP2D6—cerebellum—germ cell cancer	2.82e-05	0.000286	CbGeAlD
Pazopanib—ABCB1—adrenal gland—germ cell cancer	2.66e-05	0.000269	CbGeAlD
Pazopanib—ABCB1—midbrain—germ cell cancer	2.63e-05	0.000266	CbGeAlD
Pazopanib—ABCB1—bone marrow—germ cell cancer	2.57e-05	0.00026	CbGeAlD
Pazopanib—ABCB1—spinal cord—germ cell cancer	2.56e-05	0.000259	CbGeAlD
Pazopanib—ABCB1—female gonad—germ cell cancer	2.48e-05	0.000251	CbGeAlD
Pazopanib—ABCB1—endocrine gland—germ cell cancer	2.31e-05	0.000233	CbGeAlD
Pazopanib—CYP2D6—brain—germ cell cancer	2.29e-05	0.000232	CbGeAlD
Pazopanib—ABCB1—head—germ cell cancer	2.28e-05	0.00023	CbGeAlD
Pazopanib—ABCB1—testis—germ cell cancer	2.2e-05	0.000223	CbGeAlD
Pazopanib—ABCB1—cerebellum—germ cell cancer	2.03e-05	0.000206	CbGeAlD
Pazopanib—ABCB1—brain—germ cell cancer	1.65e-05	0.000167	CbGeAlD
Pazopanib—ABCB1—lymph node—germ cell cancer	1.59e-05	0.000161	CbGeAlD
Pazopanib—PDGFRA—Immune System—KITLG—germ cell cancer	9.97e-06	9.41e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CRABP1—germ cell cancer	9.92e-06	9.36e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—KITLG—germ cell cancer	9.9e-06	9.34e-05	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—KIT—germ cell cancer	9.89e-06	9.34e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—OXT—germ cell cancer	9.89e-06	9.33e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AVP—germ cell cancer	9.85e-06	9.3e-05	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	9.84e-06	9.29e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—KIT—germ cell cancer	9.82e-06	9.27e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—FGFR3—germ cell cancer	9.81e-06	9.26e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—H2AFZ—germ cell cancer	9.79e-06	9.24e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—KITLG—germ cell cancer	9.72e-06	9.18e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—OXT—germ cell cancer	9.71e-06	9.16e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—FGFR3—germ cell cancer	9.63e-06	9.09e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—H2AFZ—germ cell cancer	9.54e-06	9.01e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—HRAS—germ cell cancer	9.52e-06	8.98e-05	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	9.39e-06	8.86e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—HRAS—germ cell cancer	9.39e-06	8.86e-05	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—HRAS—germ cell cancer	9.39e-06	8.86e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—HRAS—germ cell cancer	9.35e-06	8.82e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—HRAS—germ cell cancer	9.31e-06	8.78e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—KITLG—germ cell cancer	9.23e-06	8.71e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—HRAS—germ cell cancer	9.22e-06	8.71e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—OXT—germ cell cancer	9.21e-06	8.7e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—KITLG—germ cell cancer	9.2e-06	8.69e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—FGFR3—germ cell cancer	9.2e-06	8.68e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—OXT—germ cell cancer	9.19e-06	8.67e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CRABP1—germ cell cancer	9.19e-06	8.67e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—HRAS—germ cell cancer	9.18e-06	8.67e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—H2AFZ—germ cell cancer	9.11e-06	8.59e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—H2AFZ—germ cell cancer	9.01e-06	8.51e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—KITLG—germ cell cancer	9.01e-06	8.5e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—KIT—germ cell cancer	9.01e-06	8.5e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—KITLG—germ cell cancer	8.98e-06	8.48e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.9e-06	8.4e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—FGFR3—germ cell cancer	8.89e-06	8.39e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—HRAS—germ cell cancer	8.87e-06	8.37e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—HRAS—germ cell cancer	8.85e-06	8.35e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—KIT—germ cell cancer	8.84e-06	8.34e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—FGFR3—germ cell cancer	8.83e-06	8.34e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AVP—germ cell cancer	8.81e-06	8.31e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—KITLG—germ cell cancer	8.79e-06	8.3e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—KITLG—germ cell cancer	8.78e-06	8.29e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—FGF4—germ cell cancer	8.77e-06	8.28e-05	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—HRAS—germ cell cancer	8.69e-06	8.2e-05	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—TP53—germ cell cancer	8.6e-06	8.12e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AVP—germ cell cancer	8.58e-06	8.1e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—KIT—germ cell cancer	8.44e-06	7.97e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—FGF4—germ cell cancer	8.44e-06	7.96e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KITLG—germ cell cancer	8.38e-06	7.91e-05	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	8.32e-06	7.85e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—KITLG—germ cell cancer	8.29e-06	7.83e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—FGF4—germ cell cancer	8.29e-06	7.82e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—OXT—germ cell cancer	8.28e-06	7.82e-05	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—HRAS—germ cell cancer	8.23e-06	7.77e-05	CbGpPWpGaD
Pazopanib—ITK—Immune System—HRAS—germ cell cancer	8.2e-06	7.74e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AVP—germ cell cancer	8.19e-06	7.73e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—KIT—germ cell cancer	8.16e-06	7.7e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—KIT—germ cell cancer	8.11e-06	7.65e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—OXT—germ cell cancer	8.11e-06	7.65e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—FGF4—germ cell cancer	8.1e-06	7.64e-05	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—HRAS—germ cell cancer	8.03e-06	7.58e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—HRAS—germ cell cancer	7.97e-06	7.52e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—FGFR3—germ cell cancer	7.97e-06	7.52e-05	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—HRAS—germ cell cancer	7.94e-06	7.49e-05	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—HRAS—germ cell cancer	7.89e-06	7.45e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—FGF4—germ cell cancer	7.87e-06	7.42e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—FGF4—germ cell cancer	7.84e-06	7.4e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—FGFR3—germ cell cancer	7.83e-06	7.39e-05	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—HRAS—germ cell cancer	7.79e-06	7.35e-05	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—HRAS—germ cell cancer	7.58e-06	7.15e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—H2AFZ—germ cell cancer	7.54e-06	7.11e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—FGFR3—germ cell cancer	7.43e-06	7.01e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—FGFR3—germ cell cancer	7.41e-06	6.99e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—H2AFZ—germ cell cancer	7.4e-06	6.99e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—FGFR3—germ cell cancer	7.36e-06	6.94e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—KIT—germ cell cancer	7.32e-06	6.91e-05	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—MYC—germ cell cancer	7.26e-06	6.85e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—H2AFZ—germ cell cancer	7.23e-06	6.83e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—FGFR3—germ cell cancer	7.23e-06	6.82e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—KITLG—germ cell cancer	7.21e-06	6.8e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SLC2A3—germ cell cancer	7.1e-06	6.7e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—FGF4—germ cell cancer	7.07e-06	6.67e-05	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—HRAS—germ cell cancer	7.06e-06	6.67e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—H2AFZ—germ cell cancer	7.02e-06	6.63e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—H2AFZ—germ cell cancer	7.01e-06	6.61e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SLC22A3—germ cell cancer	6.99e-06	6.6e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KITLG—germ cell cancer	6.93e-06	6.54e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—FGF4—germ cell cancer	6.92e-06	6.53e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—KIT—germ cell cancer	6.88e-06	6.49e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—FGFR3—germ cell cancer	6.86e-06	6.47e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—FGFR3—germ cell cancer	6.84e-06	6.46e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—KIT—germ cell cancer	6.82e-06	6.44e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—KITLG—germ cell cancer	6.81e-06	6.43e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—KIT—germ cell cancer	6.8e-06	6.42e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AVP—germ cell cancer	6.78e-06	6.4e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—KIT—germ cell cancer	6.76e-06	6.38e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—FGFR3—germ cell cancer	6.7e-06	6.32e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—FGFR3—germ cell cancer	6.67e-06	6.3e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AVP—germ cell cancer	6.65e-06	6.28e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—KITLG—germ cell cancer	6.65e-06	6.28e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—OXT—germ cell cancer	6.64e-06	6.27e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—MYC—germ cell cancer	6.64e-06	6.27e-05	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—HRAS—germ cell cancer	6.56e-06	6.19e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—FGFR3—germ cell cancer	6.53e-06	6.17e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—FGFR3—germ cell cancer	6.53e-06	6.16e-05	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—HRAS—germ cell cancer	6.51e-06	6.14e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KITLG—germ cell cancer	6.46e-06	6.1e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KITLG—germ cell cancer	6.44e-06	6.08e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—HRAS—germ cell cancer	6.4e-06	6.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AVP—germ cell cancer	6.32e-06	5.96e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—H2AFZ—germ cell cancer	6.31e-06	5.96e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AVP—germ cell cancer	6.3e-06	5.95e-05	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—HRAS—germ cell cancer	6.3e-06	5.95e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—KIT—germ cell cancer	6.3e-06	5.94e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—KIT—germ cell cancer	6.28e-06	5.93e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—FGFR3—germ cell cancer	6.23e-06	5.88e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SLC2A3—germ cell cancer	6.19e-06	5.84e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—H2AFZ—germ cell cancer	6.18e-06	5.83e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—FGFR3—germ cell cancer	6.16e-06	5.82e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—KIT—germ cell cancer	6.15e-06	5.8e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—KIT—germ cell cancer	6.13e-06	5.78e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SLC22A3—germ cell cancer	6.09e-06	5.75e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	6.09e-06	5.75e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—KIT—germ cell cancer	6e-06	5.66e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—KIT—germ cell cancer	5.99e-06	5.66e-05	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TP53—germ cell cancer	5.96e-06	5.63e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.89e-06	5.56e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SLC2A3—germ cell cancer	5.83e-06	5.5e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KITLG—germ cell cancer	5.81e-06	5.48e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SLC22A3—germ cell cancer	5.74e-06	5.42e-05	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—HRAS—germ cell cancer	5.73e-06	5.41e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KIT—germ cell cancer	5.72e-06	5.39e-05	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—HRAS—germ cell cancer	5.7e-06	5.38e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CRABP1—germ cell cancer	5.7e-06	5.38e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KITLG—germ cell cancer	5.68e-06	5.37e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AVP—germ cell cancer	5.68e-06	5.36e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FGF4—germ cell cancer	5.67e-06	5.35e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—KIT—germ cell cancer	5.66e-06	5.34e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AVP—germ cell cancer	5.56e-06	5.24e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TP53—germ cell cancer	5.45e-06	5.15e-05	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—HRAS—germ cell cancer	5.43e-06	5.12e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—MYC—germ cell cancer	5.4e-06	5.1e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—FGFR3—germ cell cancer	5.36e-06	5.06e-05	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—HRAS—germ cell cancer	5.33e-06	5.03e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—HRAS—germ cell cancer	5.22e-06	4.92e-05	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—HRAS—germ cell cancer	5.21e-06	4.92e-05	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—TP53—germ cell cancer	5.17e-06	4.88e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—FGFR3—germ cell cancer	5.15e-06	4.86e-05	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—HRAS—germ cell cancer	5.12e-06	4.83e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—H2AFZ—germ cell cancer	5.06e-06	4.78e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—FGFR3—germ cell cancer	5.06e-06	4.78e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—HRAS—germ cell cancer	5.06e-06	4.78e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—HRAS—germ cell cancer	5.05e-06	4.76e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—HRAS—germ cell cancer	5.04e-06	4.76e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CRABP1—germ cell cancer	4.97e-06	4.69e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—MYC—germ cell cancer	4.96e-06	4.68e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—FGFR3—germ cell cancer	4.95e-06	4.67e-05	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—HRAS—germ cell cancer	4.94e-06	4.67e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC2A3—germ cell cancer	4.94e-06	4.66e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—KIT—germ cell cancer	4.92e-06	4.64e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC22A3—germ cell cancer	4.86e-06	4.59e-05	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—HRAS—germ cell cancer	4.86e-06	4.59e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—HRAS—germ cell cancer	4.85e-06	4.57e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.84e-06	4.57e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—FGFR3—germ cell cancer	4.8e-06	4.53e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—FGFR3—germ cell cancer	4.79e-06	4.52e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KIT—germ cell cancer	4.73e-06	4.46e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CRABP1—germ cell cancer	4.68e-06	4.42e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KITLG—germ cell cancer	4.66e-06	4.4e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—HRAS—germ cell cancer	4.6e-06	4.34e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AVP—germ cell cancer	4.55e-06	4.3e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—HRAS—germ cell cancer	4.55e-06	4.29e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—KIT—germ cell cancer	4.54e-06	4.29e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—MYC—germ cell cancer	4.49e-06	4.24e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—HRAS—germ cell cancer	4.45e-06	4.2e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KIT—germ cell cancer	4.41e-06	4.16e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KIT—germ cell cancer	4.4e-06	4.15e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—HRAS—germ cell cancer	4.37e-06	4.12e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—FGFR3—germ cell cancer	4.32e-06	4.07e-05	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—HRAS—germ cell cancer	4.27e-06	4.03e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—HRAS—germ cell cancer	4.24e-06	4.01e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—germ cell cancer	4.24e-06	4e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—FGFR3—germ cell cancer	4.22e-06	3.99e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—germ cell cancer	4.07e-06	3.84e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—HRAS—germ cell cancer	4.05e-06	3.83e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CRABP1—germ cell cancer	3.97e-06	3.74e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KIT—germ cell cancer	3.96e-06	3.74e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—HRAS—germ cell cancer	3.89e-06	3.67e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KIT—germ cell cancer	3.88e-06	3.66e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HRAS—germ cell cancer	3.82e-06	3.61e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	3.81e-06	3.6e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MYC—germ cell cancer	3.78e-06	3.57e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	3.75e-06	3.54e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—MYC—germ cell cancer	3.72e-06	3.51e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—MYC—germ cell cancer	3.65e-06	3.45e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—HRAS—germ cell cancer	3.65e-06	3.44e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—HRAS—germ cell cancer	3.53e-06	3.33e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HRAS—germ cell cancer	3.5e-06	3.31e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—MYC—germ cell cancer	3.46e-06	3.27e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FGFR3—germ cell cancer	3.46e-06	3.27e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—MYC—germ cell cancer	3.46e-06	3.26e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MYC—germ cell cancer	3.38e-06	3.19e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MYC—germ cell cancer	3.3e-06	3.11e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KIT—germ cell cancer	3.18e-06	3e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HRAS—germ cell cancer	3.16e-06	2.98e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MYC—germ cell cancer	3.15e-06	2.97e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—MYC—germ cell cancer	3.11e-06	2.94e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—germ cell cancer	3.11e-06	2.93e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—HRAS—germ cell cancer	3.11e-06	2.93e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.06e-06	2.89e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HRAS—germ cell cancer	2.97e-06	2.81e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HRAS—germ cell cancer	2.95e-06	2.78e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HRAS—germ cell cancer	2.94e-06	2.77e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HRAS—germ cell cancer	2.92e-06	2.76e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—HRAS—germ cell cancer	2.87e-06	2.71e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—germ cell cancer	2.78e-06	2.62e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HRAS—germ cell cancer	2.72e-06	2.57e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HRAS—germ cell cancer	2.71e-06	2.56e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—germ cell cancer	2.71e-06	2.56e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HRAS—germ cell cancer	2.66e-06	2.51e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HRAS—germ cell cancer	2.65e-06	2.5e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MYC—germ cell cancer	2.6e-06	2.46e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—HRAS—germ cell cancer	2.59e-06	2.45e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HRAS—germ cell cancer	2.59e-06	2.44e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—germ cell cancer	2.58e-06	2.44e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MYC—germ cell cancer	2.56e-06	2.41e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—MYC—germ cell cancer	2.5e-06	2.36e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HRAS—germ cell cancer	2.47e-06	2.33e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HRAS—germ cell cancer	2.45e-06	2.31e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MYC—germ cell cancer	2.43e-06	2.29e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MYC—germ cell cancer	2.42e-06	2.28e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MYC—germ cell cancer	2.18e-06	2.06e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—germ cell cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MYC—germ cell cancer	2.13e-06	2.01e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—HRAS—germ cell cancer	2.13e-06	2.01e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—germ cell cancer	2.1e-06	1.98e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HRAS—germ cell cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HRAS—germ cell cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—germ cell cancer	1.99e-06	1.88e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—germ cell cancer	1.99e-06	1.88e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—HRAS—germ cell cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HRAS—germ cell cancer	1.91e-06	1.8e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HRAS—germ cell cancer	1.9e-06	1.79e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—germ cell cancer	1.79e-06	1.69e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—germ cell cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MYC—germ cell cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HRAS—germ cell cancer	1.71e-06	1.62e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HRAS—germ cell cancer	1.68e-06	1.58e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—germ cell cancer	1.44e-06	1.36e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HRAS—germ cell cancer	1.37e-06	1.3e-05	CbGpPWpGaD
